Veracyte (VCYT) Operating Leases (2019 - 2026)

Veracyte (VCYT) has 8 years of Operating Leases data on file, last reported at $35.0 million in Q1 2026.

• Quarterly Operating Leases fell 18.81% year-over-year to $35.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $35.0 million (down 18.81% YoY) and the FY2025 annual result came in at $35.6 million, down 17.66% from the prior year.
• Operating Leases retreated to $35.0 million in Q1 2026 per VCYT's latest filing, from $35.6 million in the prior quarter.
• The five-year high for Operating Leases was $50.6 million in Q2 2025, with the low at $7.5 million in Q4 2023.
• Average Operating Leases over 5 years is $22.4 million, with a median of $14.0 million recorded in 2024.
• Year-over-year, Operating Leases tumbled 34.88% in 2022 and soared 474.58% in 2024.
• Veracyte's Operating Leases stood at $10.6 million in 2022, then retreated by 29.33% to $7.5 million in 2023, then soared by 474.58% to $43.2 million in 2024, then slipped by 17.66% to $35.6 million in 2025, then decreased by 1.73% to $35.0 million in 2026.
• Business Quant data shows VCYT's Operating Leases at $35.0 million in Q1 2026, $35.6 million in Q4 2025, and $36.2 million in Q3 2025.